Association of selective serotonin re‐uptake inhibitor (SSRI) treatment with acute substance misuse outcomes

Background and aims Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed medications for patients with anxiety/depression. These patients often have problems with substance use, but it remains unclear whether the risk of substance misuse is influenced by SSRI treatment. We aimed to...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Addiction (Abingdon, England) England), 2022-01, Vol.117 (1), p.234-242
Hauptverfasser:	Virtanen, Suvi, Lagerberg, Tyra, Khemiri, Lotfi, Suvisaari, Jaana, Larsson, Henrik, Lichtenstein, Paul, Chang, Zheng, Latvala, Antti
Format:	Artikel
Sprache:	eng
Schlagworte:	Antidepressants Anxiety Causality Cohort analysis Cohort Studies Depression Depressive personality disorders Drug abuse Drug use Female Humans longitudinal Male Medical diagnosis Mental depression Offenses Patients register‐based Regression analysis Serotonin Serotonin reuptake inhibitors Serotonin uptake inhibitors Serotonin Uptake Inhibitors - therapeutic use SSRI Substance abuse Substance use Substance-Related Disorders - epidemiology Uptake Women
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!